We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Polycarbonate Blend Ideal for Medical and Diagnostic Equipment

By LabMedica International staff writers
Posted on 01 Apr 2010
A new polycarbonate/acrylonitrile-butadiene-styrene (PC/ABS) blend is suitable for applications in medical technology, including the manufacture of diagnostic equipment.

In addition to its excellent impact resistance, stiffness, dimensional and color stability, heat resistance and processing properties, the Bayblend M850XF product grade satisfies the biocompatibility requirements of International Organization for Standardization (ISO) 10933 Part 1 as modified by the U.S. Federal Drug Administration (FDA; Silver Springs, MD, USA). The new Bayblend grade can be sterilized by ethylene oxide (EtO), gamma radiation, or electron rays.

Bayer MaterialScience (Leverkusen, Germany) developed Bayblend M850XF, expanding its portfolio of PC/ABS. The product is particularly suitable for injection molding thin-walled components.

"Bayblend M850XF offers the balanced combination of processability and physical properties required for components used in medical and diagnostic equipment," explained Markus Krieter, an expert for applications in medical technology at Bayer MaterialScience.

Bayer MaterialScience is focused on the manufacture of high-tech polymer materials. It is a Bayer Group company.

Related Links:

U.S. Federal Drug Administration
Bayer MaterialScience



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Sepsis Test
SeptiCyte RAPID
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]

Latest Technology News

New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
01 Apr 2010  |   Technology

Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
01 Apr 2010  |   Technology

Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
01 Apr 2010  |   Technology



INTEGRA BIOSCIENCES AG